Stroke is the fifth-leading cause of death nationwide. Brain damage from strokes can be minimized if they are treated ...

Assistive technology developed at the University of São Paulo helps patients with reduced muscle strength or unilateral paralysis perform daily activities and regain lost body awareness.

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem ...

Realizing this could be a critical emergency requiring neurosurgical intervention, I knew we had to get to the ER as quickly ...

A Gering teenager is on the road to recovery after a life-threatening ATV accident and subsequent stroke, thanks to the swift ...

Dr. Ryan McMorries examines Sheilah Horton at the ER unit of Hartselle Health Park. The facility has 10 treatment rooms ...

The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Share on Pinterest A new study found that moderate stress levels were associated with a 78% increased risk of stroke in female participants, but not in males. ozgurcankaya/Getty Images Stress is ...